Pleo Ex - 60681-1003-1 - (candida albicans, candida parapsilosis, and penicillium roqueforti)

Alphabetical Index


Drug Information of Pleo Ex

Product NDC: 60681-1003
Proprietary Name: Pleo Ex
Non Proprietary Name: candida albicans, candida parapsilosis, and penicillium roqueforti
Active Ingredient(s): 5; 5; 5    [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL & nbsp;   candida albicans, candida parapsilosis, and penicillium roqueforti
Administration Route(s): ORAL
Dosage Form(s): SOLUTION/ DROPS
Coding System: National Drug Codes(NDC)

Labeler Information of Pleo Ex

Product NDC: 60681-1003
Labeler Name: Sanum Kehlbeck GmbH & Co. KG
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date: 20100615

Package Information of Pleo Ex

Package NDC: 60681-1003-1
Package Description: 1 BOTTLE, DROPPER in 1 CARTON (60681-1003-1) > 10 mL in 1 BOTTLE, DROPPER

NDC Information of Pleo Ex

NDC Code 60681-1003-1
Proprietary Name Pleo Ex
Package Description 1 BOTTLE, DROPPER in 1 CARTON (60681-1003-1) > 10 mL in 1 BOTTLE, DROPPER
Product NDC 60681-1003
Product Type Name HUMAN OTC DRUG
Non Proprietary Name candida albicans, candida parapsilosis, and penicillium roqueforti
Dosage Form Name SOLUTION/ DROPS
Route Name ORAL
Start Marketing Date 20100615
Marketing Category Name UNAPPROVED HOMEOPATHIC
Labeler Name Sanum Kehlbeck GmbH & Co. KG
Substance Name CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; PENICILLIUM ROQUEFORTI
Strength Number 5; 5; 5
Strength Unit [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL
Pharmaceutical Classes

Complete Information of Pleo Ex


General Information